Rhabdomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
Conditions:   Solid Tumor;   Lymphoma;   Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcoma Intervention:   Drug: Surufatinib in combination with Gemcitabine Sponsor:   Hutchison Medipharma Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2021 Category: Research Source Type: clinical trials